Benefits of SGLT2 inhibitors combining with renin-angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis.

Liu, Ting; Li, Rui; Wang, Xiaoxia; Gao, Xingxing; Zhang, Xiaodong

Liu, Ting; Li, Rui; Wang, Xiaoxia; Gao, Xingxing; Zhang, Xiaodong.

Affiliation

Liu T; Department of Nephrology, The First Hospital of Shanxi Medical University, Taiyuan, China.
Li R; Shanxi Medical University, Taiyuan, China.
Wang X; Shanxi Medical University, Taiyuan, China.
Gao X; Shanxi Medical University, Taiyuan, China.
Zhang X; Department of Nephrology, The First Hospital of Shanxi Medical University, Taiyuan, China. Electronic address: zxdspl@163.com.

Med Clin (Barc) ; 159(2): 65-72, 2022 07 22.

Article in En, Es | MEDLINE | ID: mdl-34872768

Subject(s)

Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors; Angiotensin Receptor Antagonists/pharmacology; Angiotensin Receptor Antagonists/therapeutic use; Angiotensins/therapeutic use; Glucose/therapeutic use; Humans; Renal Insufficiency, Chronic/complications; Renal Insufficiency, Chronic/drug therapy; Renin/therapeutic use; Sodium; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use

Key words

Bloqueadores del SRA; Cardiovascular outcomes; Chronic kidney disease; Enfermedad renal crónica; Inhibidores del cotransportador de sodio-glucosa 2; Meta-analysis; Metaanálisis; RAS blockers; Resultados cardiovasculares; Sodium-glucose co-transporter 2 inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En / Es Journal: Med Clin (Barc) Year: 2022 Type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google